Who
Christian Behrenbruch
MD & Group CEO
Company insider
Files Form 4 as: MD & Group CEO, Telix Pharmaceuticals.
In numbers
- Trades disclosed
- 4
- Buys
- 2
- Sells
- 0
- Bought
- $2.0M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 28 Apr 2026
- Last trade
- 29 Apr 2026
- Last filed
- 6 May 2026
Companies traded
Activity over time
1 Apr – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Apr 2026filed 6 May 2026 | TLX Telix PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $497K33,435 at $14.87 | filing |
| 29 Apr 2026filed 6 May 2026 | TLX Telix PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $497K33,435 at $14.87 | filing |
| 28 Apr 2026filed 6 May 2026 | TLX Telix PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $500K34,500 at $14.48 | filing |
| 28 Apr 2026filed 6 May 2026 | TLX Telix PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $500K34,500 at $14.48 | filing |
News
No headline names them, or the companies they trade most, lately.